Abstract POSTER-CTRL-1211: Haptoglobin identified within ovarian cyst fluid as an accurate intraoperative diagnostic biomarker for epithelial ovarian cancer

Author(s):  
Mahesh Choolani ◽  
Loganath Annamalai ◽  
Lin Liu ◽  
Khalil Razvi ◽  
Changqing Zhao ◽  
...  
2019 ◽  
Vol Volume 11 ◽  
pp. 1115-1124 ◽  
Author(s):  
Jayakumar Perumal ◽  
Aniza Mahyuddin ◽  
Ghayathri Balasundaram ◽  
Douglas Goh ◽  
Chit Yaw Fu ◽  
...  

2009 ◽  
Vol 18 (8) ◽  
pp. 2176-2181 ◽  
Author(s):  
E. Kolwijck ◽  
P. L.M. Zusterzeel ◽  
H. M.J. Roelofs ◽  
J. C. Hendriks ◽  
W. H.M. Peters ◽  
...  

2017 ◽  
Vol 126 (2) ◽  
pp. 112-121 ◽  
Author(s):  
Amy G. Zhou ◽  
Kimberly L. Levinson ◽  
Dorothy L. Rosenthal ◽  
Christopher J. VandenBussche

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Huan Wang ◽  
Ziyi Fu ◽  
Chencheng Dai ◽  
Jian Cao ◽  
Xiaoguang Liu ◽  
...  

2019 ◽  
Vol 37 (1) ◽  
pp. 72-78
Author(s):  
Steven J. Baumrucker ◽  
Wendy H. Vogel ◽  
Robert M. Stolick ◽  
Russell W. Adkins ◽  
Heather Holland ◽  
...  

JM is a 32-year-old primagravida with polycystic ovary disease. She had extreme difficulty conceiving and was started on clomiphene 6 months ago by her fertility specialist. After doubling the dose on the sixth cycle, she successfully became pregnant. On her second prenatal visit at 12 weeks gestation, an ovarian cyst was detected. Ultrasound showed a complex ovarian mass with nodules on the bowel and abdominal wall. There was mild-to-moderate peritoneal fluid. Cytology showed adenocarcinoma of ovarian origin. Further workup demonstrated advanced stage III epithelial ovarian cancer. JM was referred to GYN-oncology who felt pregnancy-sparing debulking was not an option. The oncologist recommended termination of pregnancy due to the risks of delaying chemotherapy. JM refused, citing her fertility difficulties in the past and her desire to carry the pregnancy to term “even if it kills me.” She tells the oncologist she cannot bear the thought of terminating her pregnancy under any circumstances. The oncologist wants to comply with her wishes but feels the patient is making a choice that would result in harm to herself. The oncology team requests an ethics consult.


1969 ◽  
Vol 44 (3) ◽  
pp. 335-348 ◽  
Author(s):  
J. R. T. COUTTS ◽  
M. C. MACNAUGHTON ◽  
P. E. ROSS ◽  
J. WALKER

SUMMARY In a case of hydatidiform mole accompanied by theca lutein cysts there was a greatly increased urinary excretion of pregnanetriol. Incubation of the mole tissue with [4-14C]pregnenolone resulted in the formation of 17α-hydroxypregnenolone, progesterone, 16α-hydroxyprogesterone and 16βhydroxyprogesterone. Cholesterol, pregnenolone, 17α-hydroxypregnenolone, pregnanediol, pregnanetriol and androstenedione were isolated from both the mole tissue itself and from the ovarian cyst fluid. Progesterone and 17α-hydroxyprogesterone were characterized only from the cyst fluid. Greater quantities of the metabolic intermediates between pregnenolone and pregnanetriol were isolated from the cyst fluid than from the mole tissue. On the basis of these results it is concluded that although the mole tissue is active in steroid metabolism the increased urinary excretion of pregnanetriol is a function of the polycystic ovaries.


1990 ◽  
Vol 6 (3) ◽  
pp. 160-163 ◽  
Author(s):  
Marguerite M. Pinto ◽  
Larry H. Bernstein ◽  
Dennis A. Brogan ◽  
Firuza Parikh ◽  
Gaby Lavy

Sign in / Sign up

Export Citation Format

Share Document